Catalyst Wire Dossier Catalyst Wire Dossier

Difelikefalin (Korsuva)

difelikefalin · Cara Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Difelikefalin (Korsuva), covering 2024-06-21 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica [Phase 2, Phase 3]

See pricing